Audrey D. ZhangNov 21, 2022

Great to see new attention to this study showing unintended consequences to #FDA's Unapproved Drugs Initiative - also a great example of how #HealthServicesResearch can contribute to policy change, since the UDI was terminated in 2020, citing this work: https://www.govinfo.gov/content/pkg/FR-2020-11-25/pdf/2020-26133.pdf #HealthPolicy #RxPolicy

QT @iwashyna
ok, like half of the useful non-antibiotic #ICU #drugs are apparently #UnapprovedByFDA

Source: #RaviGupta #JoeRoss in https://pubmed.ncbi.nlm.nih.gov/28944731/

Jack Iwashyna 🫁Nov 21, 2022

ok, like half of the useful non-antibiotic #ICU #drugs are apparently #UnapprovedByFDA

Source: #RaviGupta #JoeRoss in https://pubmed.ncbi.nlm.nih.gov/28944731/

#WTF
#atropine #epinephrine #hydrocodone #levothyroxine #morphine #nitroglycerine #oxycodone #pancrelipase #phenylephrine #vasopressin

#MedMastodon

The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States - PubMed

This project was not supported by any external grants or funds. Gupta was supported by the Yale University School of Medicine Office of Student Research at the time of this study. Dhruva is supported by the Department of Veterans Affairs as part of the Robert Wood Johnson Foundation Clinical Scholar …

PubMed